E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/5/2010 in the Prospect News PIPE Daily.

New Issue: Omni Bio Pharmaceutical plans $2.5 million private placement of units

By Devika Patel

Knoxville, Tenn., Jan. 5 - Omni Bio Pharmaceutical Inc. arranged a $2.5 million private placement of units, according to an 8-K filed Tuesday with the Securities and Exchange Commission. It raised $365,000 on Dec. 29 and $25,000 on Dec. 31.

The company is selling up to 1 million units at $2.50 apiece. It sold 146,000 units on Dec. 29 and 10,000 units on Dec. 31.

Each unit consists of one common share and one warrant. Each warrant is exercisable at $3.75 for five years.

Proceeds will be used for research and development and for general working capital.

The mortgage broker for commercial real estate transactions is based in Greenwood Village, Colo.

Issuer:Omni Bio Pharmaceutical Inc.
Issue:Units of one common share and one warrant
Amount:$2.5 million
Units:1 million
Price:$2.50
Warrants:One warrant per unit
Warrant expiration:Five years
Warrant strike price:$3.75
Settlement date:Dec. 29 (for $365,000), Dec. 31 (for $25,000)
Stock symbol:OTCBB: OMBP
Stock price:$11.05 at close Dec. 29
Market capitalization:$322 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.